Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7075448
Reference Type
Journal Article
Subtype
Review
Title
New Molecular Targets and Strategies for Antimalarial Discovery
Author(s)
Aguiar, AC; de Sousa, LRF; Garcia, CRS; Oliva, G; Guido, RVC; ,
Year
2019
Is Peer Reviewed?
Yes
Journal
Current Medicinal Chemistry
ISSN:
0929-8673
EISSN:
1875-533X
Publisher
BENTHAM SCIENCE PUBL LTD
Location
SHARJAH
Volume
26
Issue
23
Page Numbers
4380-4402
Language
English
PMID
28875841
DOI
10.2174/0929867324666170830103003
Web of Science Id
WOS:000489555700005
Abstract
Malaria remains a major health problem, especially because of the emergence of resistant P. falciparum strains to artemisinin derivatives. In this context, safe and affordable antimalarial drugs are desperately needed. New proteins have been investigated as molecular targets for research and development of innovative compounds with well-defined mechanism of action. In this review, we highlight genetically and clinically validated plasmodial proteins as drug targets for the next generation of therapeutics. The enzymes described herein are involved in hemoglobin hydrolysis, the invasion process, elongation factors for protein synthesis, pyrimidine biosynthesis, post-translational modifications such as prenylation, phosphorylation and histone acetylation, generation of ATP in mitochondrial metabolism and aminoacylation of RNAs. Significant advances on proteomics, genetics, structural biology, computational and biophysical methods provided invaluable molecular and structural information about these drug targets. Based on this, several strategies and models have been applied to identify and improve lead compounds. This review presents the recent progresses in the discovery of antimalarial drug candidates, highlighting the approaches, challenges, and perspectives to deliver affordable, safe and low single-dose medicines to treat malaria.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity